ID: ALA3277930

Max Phase: Preclinical

Molecular Formula: C26H25ClN4O2

Molecular Weight: 424.50

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.N=C(N)c1cccc(OCc2ccc3cc(COc4cccc(C(=N)N)c4)ccc3c2)c1

Standard InChI:  InChI=1S/C26H24N4O2.ClH/c27-25(28)21-3-1-5-23(13-21)31-15-17-7-9-20-12-18(8-10-19(20)11-17)16-32-24-6-2-4-22(14-24)26(29)30;/h1-14H,15-16H2,(H3,27,28)(H3,29,30);1H

Standard InChI Key:  HIKBSRIKHBEKDQ-UHFFFAOYSA-N

Associated Targets(Human)

Thrombin 11687 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Thrombin 1630 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glandular kallikrein 81 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 424.50Molecular Weight (Monoisotopic): 424.1899AlogP: 4.57#Rotatable Bonds: 8
Polar Surface Area: 118.20Molecular Species: BASEHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 11.46CX LogP: 3.94CX LogD: -0.86
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.24Np Likeness Score: -0.32

References

1. Geratz JD, Cheng MC, Tidwell RR..  (1976)  Novel bis(benzamidino) compounds with an aromatic central link. Inhibitors of thrombin, pancreatic kallikrein, trypsin, and complement.,  19  (5): [PMID:1271404] [10.1021/jm00227a011]

Source